![](/img/cover-not-exists.png)
PCN135 COST-EFFECTIVENESS STUDY OF ALECTINIB VERSUS CRIZOTINIB IN FIRST-LINE TREATMENT FOR ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NSCLC IN CHINA
Zhang, L., Zhou, C., Zhao, J., Hu, J., Dong, X., Liu, C., Peng, X., Ming, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.259
Date:
May, 2019
File:
PDF, 652 KB
2019